StonvexLoading…
StonvexStonvexStonvexCore line items from WBS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $237.97M | $245.70M | $233.40M | $268.67M |
Operating Income | $1.47B | $1.24B | $1.24B | $1.08B |
Net Income | $1.00B | $768.71M | $867.84M | $644.28M |
EPS (Diluted) | $5.90 | $4.37 | $4.91 | $3.72 |
Total Assets | $84.07B | $79.03B | $74.95B | $71.28B |
Total Liabilities | $74.58B | $69.89B | $66.26B | $63.22B |
Cash & Equivalents | $2.45B | $2.07B | $1.72B | $839.94M |
Free Cash Flow OCF − CapEx | $1.01B | $1.37B | $938.35M | $1.31B |
Shares Outstanding | 161.22M | 171.39M | 172.02M | 174.01M |